surpass trial tirzepatide New research from the SURPASS-EARLY found that improved glycemic control, body weight, and waist circumference over 104 weeks compared with intensified conventional care in adults with early type 2 diabetes Tirzepatide outcompetes long-acting insulin in

If you have any specific product queries, please contact the manufacturer

Apoio ao controle do apetite

A study of 42,000 adults found increased rates of hypotension events after starting GLP-1s

Pfizers dose-optimization studies of once-daily formulations of danuglipron ( NCT06567327 and NCT06568731 ) met key pharmacokinetic objectives and confirmed a formulation and dose with the potential to deliver a competitive efficacy and tolerability profile in Phase 3 testing, based on earlier studies of twice-daily danuglipron

Learn what Ozempic face is, why rapid weight loss causes facial volume loss, and the best treatments to restore a youthful, natural look.

As the cold months settle in, many people start thinking about ways to stay healthy and shed those extra pounds before the summer months arrive